BrainCool AB (publ) - inlösenperiod för BrainCools optioner, BRAIN TO 3, 2019 - 2022, 22 februari – 8 mars 2021
![InvestTalks Podcast ⎮ Martin Waleij , VD BrainCool AB (publ) (BRAIN): BrainCool ökar omsättningen och står inför avgörande marknadsgenombrott i USA - Invest Talks - Content Relations Sverige InvestTalks Podcast ⎮ Martin Waleij , VD BrainCool AB (publ) (BRAIN): BrainCool ökar omsättningen och står inför avgörande marknadsgenombrott i USA - Invest Talks - Content Relations Sverige](https://mb.cision.com/Public/19789/3603107/82d9c53183d9cc0c_800x800ar.png)
InvestTalks Podcast ⎮ Martin Waleij , VD BrainCool AB (publ) (BRAIN): BrainCool ökar omsättningen och står inför avgörande marknadsgenombrott i USA - Invest Talks - Content Relations Sverige
![FDA Breakthrough Device Designation Awarded To BrainCool AB's Cooral System | Medical Product Outsourcing FDA Breakthrough Device Designation Awarded To BrainCool AB's Cooral System | Medical Product Outsourcing](https://images.rodpub.com/images/228/822_main.jpg)
FDA Breakthrough Device Designation Awarded To BrainCool AB's Cooral System | Medical Product Outsourcing
![BrainCool AB (publ) update of EU grant (BRAINCELL – combined TTM / thrombectomy treatment) - BrainCool BrainCool AB (publ) update of EU grant (BRAINCELL – combined TTM / thrombectomy treatment) - BrainCool](https://mb.cision.com/Public/11624/3443855/87e73299ca398895_800x800ar.png)